2nd Sep 2009 07:00
RNS Number : 3590Y
Synairgen plc
02 September 2009
SYNAIRGEN PLC
NOTICE OF RESULTS
Synairgen plc (LSE: SNG), the drug discovery and development company focused on asthma and chronic obstructive pulmonary disease ('COPD'), will be announcing its full year results for the year ended 30 June 2009 on Friday 4 September 2009.
Ends
For further information, please contact:
Synairgen |
Tel: + 44 (0) 2380 512 800 |
Richard Marsden, Managing Director John Ward, Finance Director or email [email protected] |
|
Threadneedle Communications Tel: + 44 (0) 20 7653 9850 Graham Herring |
This information is provided by RNS
The company news service from the London Stock Exchange
Related Shares:
Synairgen